Fig. 1From: The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in ChinaThe cumulative incidence of TEEs in ROS1 rearranged NSCLC analyzed by competing risk analysisBack to article page